ALZN (Alzamend Neuro, Inc.) Net Profit

Official company branding of alzamend.com (ALZN)

Alzamend Neuro, Inc. (ALZN) profit margins reflect daily financial results, where -0.01 represents the current level of the indicator. Patents for lithium complexes and strict FDA oversight create a high barrier to entry. Efficiency is enhanced through the automation of geriatric data analysis, while operational flexibility is achieved by outsourcing production and trials to third-party contractors.

ALZN: Alzamend Neuro Net Income 07/04/2022 - 10/31/2026

Analytical breakdowns and data insights for company alzamend.com (ALZN)

- stock value and consensus price forecast:
Market Price Alzamend Neuro|ALZN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Alzamend Neuro|ALZN - Total Company Value
- book capitalization data:
Net Assets per Single Share Alzamend Neuro|ALZN - Company Net Assets|Market Capitalization to Net Assets alzamend.com|ALZN - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Alzamend Neuro, Inc.|ALZN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Alzamend Neuro|ALZN - Company Aggregate Debts|Debts to Book Value Alzamend Neuro|ALZN - Company Long-Term Debt|Company Short-Term Indebtedness Alzamend Neuro|Immediate Liquidity Ratio alzamend.com
- earnings and valuation multiples information:
ALZN - Net Income
Fundamental valuation:ALZN Alzamend
Manufactured product of Alzamend Neuro Inc.

Alzamend Neuro, Inc. (ALZN) possesses high macro-resilience, as the development of Alzheimer's disease treatments is independent of economic cycles and seasonality. By analyzing the company's annual net income, an investor assesses the final financial result net of all expenses, which allows them to filter out market noise, determine the business's actual creditworthiness, and forecast the asset's long-term value based on clinical successes.

Main competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Profit regencellbioscience.com|Company Net Income Axsome Therapeutics, Inc. (AXSM)|Company Net Income ACAD (ACADIA Pharma)|Xenon Pharmaceuticals Inc - Net Income|VKTX (Viking Therapeutics Corp) - Profit After Tax|Supernus Pharmaceuticals - Net Profit|CPRX - Net Profit|Denali Therapeutics Inc. (DNLI) - Company Net Income|Net Income Harmony Biosciences Inc|BHVN (Biohaven Pharmaceutical) - Net Profit|Company Net Income Amylyx Corp AMLX|Company Net Income Trevi Therapeutics (TRVI)|praxismedicines.com - Company Profit|Net Profit AVXL (Anavex Life Sciences Corp.)|CBLL: Company Profit|PRTA: Net Income|Final Profit ALEC (Alector, Inc.)|Annexon, Inc. (ANNX) - Company Net Income|Company Profit OMER|NGNE (Neurogene) - Net Profit|Company Net Income AC Immune S.A. ACIU|Net Income VYGR (Voyager Pharma)|Net Profit Neumora Corp (NMRA)|Company Net Income Scilex Holding Company SCLX|Final Profit TVGN|ACOG - Company Net Income|Company Net Income cogrx.com|IKT (Inhibikase) - Net Income|Cassava Pharma - Final Profit|ASRT (Assertio Holdings) - Net Profit|Coya (COYA) - Net Financial Result|Company Net Income Vistagen Therapeutics (VTGN)|ovidrx.com - Company Profit|Net Profit ABOS (Acumen Pharma)|CRVO - Net Income|ATHE: Net Income|Net Financial Result Clene Inc. CLNN|PEPG: Net Profit|jupiterneurosciences.com (JUNS) - Net Profit|Company Net Income Relmada|Company Net Income ANVS|Net Income GRCE (Grace Therapeutics, Inc.)|AIFF: Profit After Tax|Company Net Income Klotho Neurosciences KLTO|NRSN: Company Profit|RVPH - Company Net Income|MTVA (MetaVia Inc) - Company Profit|NRXS: Net Profit|Company Net Income Helius Medical Technologies (HSDT)|Net Income PASG|Net Profit Neuphoria|Company Net Income Minerva Neurosciences Corp (NERV)|ATHA (Athira Pharma Corp) - Final Profit|Company Net Income Addex Therapeutics ADXN|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|Protagenic - Net Profit|KTTA - Net Profit|cortigent.com (CRGT) - Company Net Income|ATXI (Avenue Therapeutics Inc) - Company Net Income|Net Income BCLI|caratherapeutics.com - Profit After Tax|Net Profit CHRO|Net Profit eliemtx.com (ELYM)|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH - Net Income|Marinus Pharmaceuticals - Net Profit|Company Net Income nkgenbiotech.com|NeuroBo Pharmaceuticals, Inc. (NRBO) - Company Net Income|Company Profit SAGE|SNPX (Neurotrope) - Net Profit|Company Profit TRVN (Trevena Inc)|Net Income VIGL (Vigil Neuroscience)|WENA (Anew Medical Inc.) - Final Profit|Company Net Income Cerevel Therapeutics, Inc. CERE